Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1998Alimentary Pharmacology & TherapeuticsOpen Access

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

View Full Paper
Ask AI
Bookmark
Share

Authors

GGreenKKerrSSwarbrick

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Green et al. (1998) studied this question.

synapsesocial.com/papers/6aa019771f0ba8eae6babbafhttps://doi.org/10.1046/j.1365-2036.1998.00427.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype1973 · 449 citations
  2. 2An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis1996 · 156 citations
  3. 3Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazine1988 · 85 citations